Together, we innovate, we impact, we grow !At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by the people behind every treatment — the patients and their families.Through our unique “development only” model, we bring forward promising therapies and transform them into treatments that can reach those who need them most, faster.Are you ready to pioneer regulatory pathways that bring life-saving therapies to patients faster? We are currently looking for a dynamic Global Program Regulatory Lead to shape the future of our pipeline. In this pivotal role, you will be the strategic regulatory voice across Project Teams, defining global regulatory strategies for innovative medicines—including small molecules, biologics, and radiopharmaceuticals—from first-in-human studies through to registration. Your mission is to maximize compound value, navigate complex global regulatory landscapes, and accelerate early access for patients with high unmet medical needs. The role is part of the Regulatory Affairs team and will be based at our Headquarters in Lausanne, Switzerland. Global Program Regulatory LeadPermanent role, full time | Lausanne, SwitzerlandExecutive Summary of ResponsibilitiesAs the Global Program Regulatory Lead, you are responsible for defining, developing, and executing end-to-end global regulatory strategies across assigned development projects. Reporting to the Head of Regulatory Affairs, you will act as the primary interface with health authorities (FDA, EMA, and beyond), lead cross-functional regulatory sub-teams, support business development opportunities, and mentor junior regulatory professionals to drive operational excellence and compliance. Key Tasks & ResponsibilitiesStrategic Regulatory Leadership: Develop and implement end-to-end global regulatory strategies for innovative drug projects across preclinical, clinical, and registration phases. Health Authority Interaction: Act as the primary interface for key regulatory agencies (FDA, EMA, etc.), coordinating and leading agency meetings and negotiations. Global Submissions: Accountable for key global filings including INDs/CTAs, Briefing Documents, Orphan Drug Designations, PIP/PSPs, and expedited pathways (Fast Track, Breakthrough, PRIME). Cross-Functional Governance: Represent Regulatory Affairs on Project and Clinical Study Teams, presenting and defending strategic plans to internal governance bodies. Document Ownership: Review, approve, and coordinate expert contributions for crucial deliverables such as Clinical Study Protocols, CSRs, SAPs, and DSURs. Business Development & Intelligence: Support in-licensing evaluations and out-licensing teams while monitoring the competitive and regulatory landscape to mitigate project impacts. Vendor & Sub-team Oversight: Lead matrixed regulatory sub-teams and manage external regulatory vendors/CROs to ensure high-quality execution. Process excellence: Strive for continuous process optimization within RA and cross-functionally, including contributing to SOP management. People Management: Manage, coach and contribute to the development of junior regulatory team members. RequirementsProfile RequiredEducational Foundation: Bachelor’s degree in life sciences; a Master’s degree or PhD/PharmD is strongly preferred. Regulatory Expertise: 10+ years of regulatory affairs experience in innovative medicines, preferably in oncology or anti-infectives, with thorough knowledge of the overall drug development process; experience with regulatory strategies spanning first-in-human through Phase 3 design and registration a strong asset. Agency Engagement: Proven track record of directly leading meetings with regulatory agencies (US & EU experience required; other global markets an asset). Submission Track Record: Demonstrated success leading cross-functional teams in preparing major regulatory deliverables, expedited pathways, and global trial applications. Matrix Leadership: Strong ability to lead cross-functional sub-teams and influence outcomes across a matrix organization with agility and purpose. Problem-Solving & Autonomy: Independent, results-driven professional capable of innovating, analyzing, and solving critical regulatory challenges with minimal supervision. BD & Lifecycle Awareness: Familiarity with business development assessments (in/out-licensing) as well as lifecycle management or innovative formulation strategies. Communication & Languages: Excellent organizational and communication skills in English; fluency or working knowledge of French is a distinct advantage. BenefitsWhat We OfferBeing part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day Partner with teams across disciplines, at the forefront of oncology and anti-infective development An inclusive and respectful workplace — proud to be Equal-Pay certified Grow in a culture that values people, purpose, and performance A chance to grow, share, and shape the future of healthcare What to Expect in the Recruitment ProcessIf your application is selected, you’ll be invited to interviews with Talent Acquisition and the Hiring Manager via Teams, followed by a panel interview and reference checks. Communication is handled via Workable—check your spam folder for emails from *@outbound.workable.com. Please contact our HR Department prior to submitting any profiles. We cannot accept unsolicited applications from agencies or recruiters.
Together, we innovate, we impact, we grow !
At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by the people behind every treatment — the patients and their families.
Through our unique “development only” model, we bring forward promising therapies and transform them into treatments that can reach those who need them most, faster.
Are you ready to pioneer regulatory pathways that bring life-saving therapies to patients faster?
We are currently looking for a dynamic Global Program Regulatory Lead to shape the future of our pipeline. In this pivotal role, you will be the strategic regulatory voice across Project Teams, defining global regulatory strategies for innovative medicines—including small molecules, biologics, and radiopharmaceuticals—from first-in-human studies through to registration. Your mission is to maximize compound value, navigate complex global regulatory landscapes, and accelerate early access for patients with high unmet medical needs. The role is part of the Regulatory Affairs team and will be based at our Headquarters in Lausanne, Switzerland.
Global Program Regulatory Lead
Permanent role, full time | Lausanne, Switzerland
Executive Summary of Responsibilities
As the Global Program Regulatory Lead, you are responsible for defining, developing, and executing end-to-end global regulatory strategies across assigned development projects. Reporting to the Head of Regulatory Affairs, you will act as the primary interface with health authorities (FDA, EMA, and beyond), lead cross-functional regulatory sub-teams, support business development opportunities, and mentor junior regulatory professionals to drive operational excellence and compliance.
Key Tasks & Responsibilities
- Strategic Regulatory Leadership: Develop and implement end-to-end global regulatory strategies for innovative drug projects across preclinical, clinical, and registration phases.
- Health Authority Interaction: Act as the primary interface for key regulatory agencies (FDA, EMA, etc.), coordinating and leading agency meetings and negotiations.
- Global Submissions: Accountable for key global filings including INDs/CTAs, Briefing Documents, Orphan Drug Designations, PIP/PSPs, and expedited pathways (Fast Track, Breakthrough, PRIME).
- Cross-Functional Governance: Represent Regulatory Affairs on Project and Clinical Study Teams, presenting and defending strategic plans to internal governance bodies.
- Document Ownership: Review, approve, and coordinate expert contributions for crucial deliverables such as Clinical Study Protocols, CSRs, SAPs, and DSURs.
- Business Development & Intelligence: Support in-licensing evaluations and out-licensing teams while monitoring the competitive and regulatory landscape to mitigate project impacts.
- Vendor & Sub-team Oversight: Lead matrixed regulatory sub-teams and manage external regulatory vendors/CROs to ensure high-quality execution.
- Process excellence: Strive for continuous process optimization within RA and cross-functionally, including contributing to SOP management.
- People Management: Manage, coach and contribute to the development of junior regulatory team members.
Requirements
Profile Required
- Educational Foundation: Bachelor’s degree in life sciences; a Master’s degree or PhD/PharmD is strongly preferred.
- Regulatory Expertise: 10+ years of regulatory affairs experience in innovative medicines, preferably in oncology or anti-infectives, with thorough knowledge of the overall drug development process; experience with regulatory strategies spanning first-in-human through Phase 3 design and registration a strong asset.
- Agency Engagement: Proven track record of directly leading meetings with regulatory agencies (US & EU experience required; other global markets an asset).
- Submission Track Record: Demonstrated success leading cross-functional teams in preparing major regulatory deliverables, expedited pathways, and global trial applications.
- Matrix Leadership: Strong ability to lead cross-functional sub-teams and influence outcomes across a matrix organization with agility and purpose.
- Problem-Solving & Autonomy: Independent, results-driven professional capable of innovating, analyzing, and solving critical regulatory challenges with minimal supervision.
- BD & Lifecycle Awareness: Familiarity with business development assessments (in/out-licensing) as well as lifecycle management or innovative formulation strategies.
- Communication & Languages: Excellent organizational and communication skills in English; fluency or working knowledge of French is a distinct advantage.
Benefits
What We Offer
- Being part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day
- Partner with teams across disciplines, at the forefront of oncology and anti-infective development
- An inclusive and respectful workplace — proud to be Equal-Pay certified
- Grow in a culture that values people, purpose, and performance
- A chance to grow, share, and shape the future of healthcare
What to Expect in the Recruitment Process
If your application is selected, you’ll be invited to interviews with Talent Acquisition and the Hiring Manager via Teams, followed by a panel interview and reference checks. Communication is handled via Workable—check your spam folder for emails from *@outbound.workable.com.
Please contact our HR Department prior to submitting any profiles. We cannot accept unsolicited applications from agencies or recruiters.
Debiopharm is an independent biopharmaceutical company based in Switzerland with headquarters in Lausanne(VD) and a manufacturing site in Martigny (VS).We are committed to developing innovative therapies that target high unmet medical needs in oncology and infectious diseases with a broad range of expertise in drug development, drug manufacturing as well as investment in start-ups. Through our unique business model, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Debiopharm is an independent biopharmaceutical company based in Switzerland with headquarters in Lausanne(VD) and a manufacturing site in Martigny (VS).
We are committed to developing innovative therapies that target high unmet medical needs in oncology and infectious diseases with a broad range of expertise in drug development, drug manufacturing as well as investment in start-ups.
Through our unique business model, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
